Mark Aspinall-O'Dea, n/a

Charles River Laboratories, England, United Kingdom

Technology Development Leader responsible for growing the business portfolio of the Retrogenix Screening Platform, a novel human cell microarray technology for off-target screening of whole engineered CAR T cells, antibodies, ScFvs, peptides and small molecules.

Disclosure information not submitted.

Presentation(s):

• Discovery: Innovation at Every Turn

  Monday, February 5, 2024
  12:00 PM – 1:00 PM EST